Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner Acquires 358,619 Shares

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner bought 358,619 shares of the company’s stock in a transaction dated Wednesday, November 13th. The stock was bought at an average cost of $13.74 per share, for a total transaction of $4,927,425.06. Following the acquisition, the insider now owns 5,810,700 shares of the company’s stock, valued at approximately $79,839,018. This trade represents a 6.58 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Joshua Kushner also recently made the following trade(s):

• On Monday, November 11th, Joshua Kushner bought 276,040 shares of Oscar Health stock. The stock was bought at an average cost of $13.58 per share, for a total transaction of $3,748,623.20.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $14.85 on Friday. The firm has a market capitalization of $3.59 billion, a price-to-earnings ratio of -247.50 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.91. The business’s 50 day simple moving average is $18.20 and its 200-day simple moving average is $18.26. Oscar Health, Inc. has a 12 month low of $6.93 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter in the previous year, the firm posted ($0.29) earnings per share. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. As a group, equities analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in shares of Oscar Health in the second quarter valued at $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health in the second quarter valued at $93,000. KBC Group NV increased its position in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after buying an additional 1,328 shares in the last quarter. Amalgamated Bank increased its position in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after buying an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new position in shares of Oscar Health in the third quarter valued at $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and dropped their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Finally, UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health has an average rating of “Moderate Buy” and an average price target of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.